Compound 19 (Duomirui Biotechnology)

N/A

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug NameCompound 19 (Duomirui Biotechnology)
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Institute Of Pharmaceutical Industry SdaShanghai Duomirui Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Institute Of Pharmaceutical Industry SdaShanghai Duomirui Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A